FDA Offers Draft Guidance on Presenting “Key Information” for Informed Consent
- March 08, 2024
Research sponsors and clinical investigators should present informed consent information in a clear, concise manner, including using plain language, according to recommendations in draft guidance issued by the Food and Drug Administration.
ARTICLE TAGS
You must be logged in to access this content.